Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Kristen Marie Williams. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Kristen Marie Williams har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:PCRX / Pacira BioSciences, Inc. Chief Administrative Officer 167.062
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Kristen Marie Williams. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb PCRX / Pacira BioSciences, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PCRX / Pacira BioSciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PCRX / Pacira BioSciences, Inc. Insider Trades
Insidersalg PCRX / Pacira BioSciences, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PCRX / Pacira BioSciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-06-04 PCRX Williams Kristen Marie 14.376 26,2400 14.376 26,2400 377.226 226 19.1600 -101.782 -26,98
2023-06-07 PCRX Williams Kristen Marie 1.357 37,8650 1.357 37,8650 51.383
2023-06-06 PCRX Williams Kristen Marie 1.301 38,9910 1.301 38,9910 50.727
2022-06-06 PCRX Williams Kristen Marie 3.969 61,3740 3.969 61,3740 243.593
2021-06-04 PCRX Williams Kristen Marie 3.930 61,0370 3.930 61,0370 239.875
2020-06-05 PCRX Williams Kristen Marie 5.904 48,6100 5.904 48,6100 286.993
2020-06-04 PCRX Williams Kristen Marie 2.402 46,3310 2.402 46,3310 111.287
2019-06-04 PCRX Williams Kristen Marie 2.529 42,9100 2.529 42,9100 108.519
2018-06-04 PCRX Williams Kristen Marie 2.040 33,0200 2.040 33,0200 67.361
2017-06-05 PCRX Williams Kristen Marie 1.877 43,3210 1.877 43,3210 81.314
2016-06-06 PCRX Williams Kristen Marie 600 47,1990 600 47,1990 28.319

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PCRX / Pacira BioSciences, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Kristen Marie Williams som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2026-06-05 2026-06-04 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -10.259 167.062 -5,79 22,27 -228.468 3.720.471
2026-06-05 2026-06-03 4 PCRX Pacira BioSciences, Inc.
Common Stock
F - Taxes -8.528 177.321 -4,59 22,32 -190.345 3.957.805
2026-02-13 2026-02-11 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 54.546 185.849 41,54
2026-02-03 2026-02-02 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -13.137 131.303 -9,10 20,53 -269.703 2.695.651
2026-02-03 2026-01-30 4 PCRX Pacira BioSciences, Inc.
Common Stock
F - Taxes -17.134 144.440 -10,60 20,54 -351.932 2.966.798
2025-06-05 2025-06-04 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -14.376 161.574 -8,17 26,24 -377.226 4.239.702
2025-06-05 2025-06-03 4 PCRX Pacira BioSciences, Inc.
Common Stock
F - Taxes -6.162 175.950 -3,38 26,40 -162.677 4.645.080
2025-02-04 2025-02-01 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 79.200 182.112 76,96
2024-06-13 2024-06-13 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -7.452 102.912 -6,75 28,38 -211.488 2.920.643
2024-06-13 2024-06-12 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 54.300 110.364 96,85
2024-06-05 2024-06-03 4 PCRX Pacira BioSciences, Inc.
Common Stock
F - Taxes -3.011 56.064 -5,10 30,89 -93.010 1.731.817
2024-02-07 2024-02-05 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 33.700 59.075 132,81
2023-06-16 2023-06-14 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -6.467 25.375 -20,31 37,03 -239.473 939.636
2023-06-16 2023-06-14 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 10.950 31.842 52,41
2023-06-07 2023-06-07 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -1.357 20.892 -6,10 37,86 -51.383 791.076
2023-06-07 2023-06-06 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -1.301 22.249 -5,52 38,99 -50.727 867.511
2022-06-08 2022-06-08 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 9.900 23.550 72,53
2022-06-08 2022-06-07 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -4.649 13.650 -25,41 59,51 -276.662 812.312
2022-06-08 2022-06-06 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -3.969 18.299 -17,82 61,37 -243.593 1.123.083
2022-03-23 2022-03-21 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -2.188 19.685 -10,00
2022-03-23 2022-03-21 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -2.112 10.560 -16,67
2022-03-23 2022-03-21 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -2.953 2.953 -50,00
2022-03-23 2022-03-21 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -7.253 22.268 -24,57 72,67 -527.076 1.618.216
2022-03-23 2022-03-21 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 2.188 29.521 8,00 47,65 104.258 1.406.676
2022-03-23 2022-03-21 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 2.112 27.333 8,37 43,54 91.956 1.190.079
2022-03-23 2022-03-21 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 2.953 25.221 13,26 38,35 113.248 967.225
2022-03-01 2022-02-25 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -2.050 5.906 -25,77
2022-03-01 2022-02-25 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -2.000 22.268 -8,24 67,07 -134.140 1.493.515
2022-03-01 2022-02-25 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -50 24.268 -0,21 65,00 -3.250 1.577.420
2022-03-01 2022-02-25 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 2.050 24.318 9,21 38,35 78.618 932.595
2022-03-01 2022-02-16 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -10 7.956 -0,13
2022-03-01 2022-02-16 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -10 22.268 -0,04 65,00 -650 1.447.420
2022-03-01 2022-02-16 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 10 22.278 0,04 38,35 384 854.361
2022-02-14 2022-02-10 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -800 7.966 -9,13
2022-02-14 2022-02-10 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -800 22.268 -3,47 65,18 -52.144 1.451.428
2022-02-14 2022-02-10 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 800 23.068 3,59 38,35 30.680 884.658
2022-02-08 2022-02-04 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -1.000 8.766 -10,24
2022-02-08 2022-02-04 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -1.000 22.268 -4,30 65,18 -65.180 1.451.428
2022-02-08 2022-02-04 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 1.000 23.268 4,49 38,35 38.350 892.328
2022-01-25 2022-01-21 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -200 9.766 -2,01
2022-01-25 2022-01-21 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -200 22.268 -0,89 65,41 -13.082 1.456.550
2022-01-25 2022-01-21 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 200 22.468 0,90 38,35 7.670 861.648
2022-01-20 2022-01-19 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -2.199 9.966 -18,08
2022-01-20 2022-01-19 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -2.199 22.268 -8,99 65,51 -144.056 1.458.777
2022-01-20 2022-01-19 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 2.199 24.467 9,88 38,35 84.332 938.309
2022-01-20 2022-01-18 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -13.127 21.873 -37,51
2022-01-20 2022-01-18 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -6.338 12.672 -33,34
2022-01-20 2022-01-18 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -2.600 12.165 -17,61
2022-01-20 2022-01-18 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -1.375 0 -100,00
2022-01-20 2022-01-18 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -400 22.268 -1,76 66,14 -26.456 1.472.806
2022-01-20 2022-01-18 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -23.040 22.668 -50,41 65,24 -1.503.130 1.478.860
2022-01-20 2022-01-18 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 13.127 45.708 40,29 47,65 625.502 2.177.986
2022-01-20 2022-01-18 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 6.338 32.581 24,15 43,54 275.957 1.418.577
2022-01-20 2022-01-18 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 2.600 26.243 11,00 38,35 99.710 1.006.419
2022-01-20 2022-01-18 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 1.375 23.643 6,17 44,20 60.775 1.045.021
2021-06-11 2021-06-10 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -847 22.268 -3,66 60,57 -51.303 1.348.773
2021-06-11 2021-06-10 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -4.842 23.115 -17,32 59,43 -287.760 1.373.724
2021-06-11 2021-06-09 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
A - Award 17.500 17.500
2021-06-11 2021-06-09 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 7.000 27.957 33,40
2021-06-08 2021-06-04 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -3.930 20.957 -15,79 61,04 -239.875 1.279.152
2021-04-15 2021-04-13 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -6.339 19.010 -25,01
2021-04-15 2021-04-13 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -8.859 14.765 -37,50
2021-04-15 2021-04-13 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -4.125 1.375 -75,00
2021-04-15 2021-04-13 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -2.500 0 -100,00
2021-04-15 2021-04-13 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -7.030 24.887 -22,03 68,11 -478.813 1.695.054
2021-04-15 2021-04-13 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -14.793 31.917 -31,67 66,40 -982.255 2.119.289
2021-04-15 2021-04-13 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 6.339 46.710 15,70 43,54 276.000 2.033.753
2021-04-15 2021-04-13 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 8.859 40.371 28,11 38,35 339.743 1.548.228
2021-04-15 2021-04-13 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 4.125 31.512 15,06 44,20 182.325 1.392.830
2021-04-15 2021-04-13 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 2.500 27.387 10,05 32,35 80.875 885.969
2020-09-17 2020-09-17 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -2.819 25.349 -10,01
2020-09-17 2020-09-17 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -7.878 23.624 -25,01
2020-09-17 2020-09-17 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -5.502 5.500 -50,01
2020-09-17 2020-09-17 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -5.836 2.500 -70,01
2020-09-17 2020-09-17 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -5.836 2.500 -70,01
2020-09-17 2020-09-17 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -3.200 24.887 -11,39 60,22 -192.704 1.498.695
2020-09-17 2020-09-17 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -24.671 28.087 -46,76 59,77 -1.474.586 1.678.760
2020-09-17 2020-09-17 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 2.819 52.758 5,64 43,54 122.739 2.297.083
2020-09-17 2020-09-17 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 7.878 49.939 18,73 38,35 302.121 1.915.161
2020-09-17 2020-09-17 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 5.502 42.061 15,05 44,20 243.188 1.859.096
2020-09-17 2020-09-17 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 5.836 36.559 19,00 32,35 188.795 1.182.684
2020-09-17 2020-09-17 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 5.836 30.723 23,45 40,34 235.424 1.239.366
2020-09-17 2020-09-16 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -2.816 28.168 -9,09
2020-09-17 2020-09-16 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -7.874 31.502 -20,00
2020-09-17 2020-09-16 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -5.499 11.002 -33,33
2020-09-17 2020-09-16 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -5.832 8.336 -41,16
2020-09-17 2020-09-16 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -5.832 8.336 -41,16
2020-09-17 2020-09-16 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -21.244 24.887 -46,05 60,33 -1.281.651 1.501.433
2020-09-17 2020-09-16 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -6.609 46.131 -12,53 59,54 -393.500 2.746.640
2020-09-17 2020-09-16 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 2.816 52.740 5,64 43,54 122.609 2.296.300
2020-09-17 2020-09-16 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 7.874 49.924 18,73 38,35 301.968 1.914.585
2020-09-17 2020-09-16 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 5.499 42.050 15,04 44,20 243.056 1.858.610
2020-09-17 2020-09-16 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 5.832 36.551 18,98 32,35 188.665 1.182.425
2020-09-17 2020-09-16 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 5.832 30.719 23,43 40,34 235.263 1.239.204
2020-09-17 2020-09-15 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -2.816 30.984 -8,33
2020-09-17 2020-09-15 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -7.874 39.376 -16,66
2020-09-17 2020-09-15 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -5.499 16.501 -25,00
2020-09-17 2020-09-15 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -5.832 14.168 -29,16
2020-09-17 2020-09-15 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -5.832 14.168 -29,16
2020-09-17 2020-09-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -13.231 24.887 -34,71 59,80 -791.214 1.488.243
2020-09-17 2020-09-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -14.622 38.118 -27,72 59,01 -862.844 2.249.343
2020-09-17 2020-09-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 2.816 52.740 5,64 43,54 122.609 2.296.300
2020-09-17 2020-09-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 7.874 49.924 18,73 38,35 301.968 1.914.585
2020-09-17 2020-09-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 5.499 42.050 15,04 44,20 243.056 1.858.610
2020-09-17 2020-09-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 5.832 36.551 18,98 32,35 188.665 1.182.425
2020-09-17 2020-09-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 5.832 30.719 23,43 40,34 235.263 1.239.204
2020-06-11 2020-06-09 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
A - Award 35.000 35.000
2020-06-11 2020-06-09 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 14.000 24.887 128,59
2020-06-08 2020-06-05 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -5.904 10.887 -35,16 48,61 -286.993 529.217
2020-06-08 2020-06-04 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -2.402 16.791 -12,51 46,33 -111.287 777.944
2019-08-16 2019-08-14 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -6.252 19.193 -24,57 39,49 -246.891 757.932
2019-06-06 2019-06-05 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
A - Award 33.800 33.800
2019-06-06 2019-06-05 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 5.600 25.445 28,22
2019-06-06 2019-06-04 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -2.529 19.845 -11,30 42,91 -108.519 851.549
2018-08-16 2018-08-14 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -4.773 22.374 -17,58 47,04 -224.522 1.052.473
2018-06-15 2018-06-13 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 47.250 47.250
2018-06-15 2018-06-13 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
A - Award 7.875 27.147 40,86
2018-06-06 2018-06-04 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale -2.040 19.272 -9,57 33,02 -67.361 636.361
2017-11-20 2017-11-17 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -7.857 0 -100,00
2017-11-20 2017-11-17 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.857 21.312 -26,94 40,00 -314.280 852.480
2017-11-20 2017-11-17 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 7.857 29.169 36,87 25,37 199.332 740.018
2017-11-20 2017-11-16 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -2.143 7.857 -21,43
2017-11-20 2017-11-16 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -2.143 21.312 -9,14 40,01 -85.741 852.693
2017-11-20 2017-11-16 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 2.143 23.455 10,06 25,37 54.368 595.053
2017-08-17 2017-08-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.461 21.312 -13,97 36,75 -127.192 783.216
2017-06-16 2017-06-14 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 22.000 22.000
2017-06-16 2017-06-14 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
A - Award 11.000 24.773 79,87
2017-06-07 2017-06-05 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale -1.877 13.773 -11,99 43,32 -81.314 596.660
2017-05-17 2017-05-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -11.979 0 -100,00
2017-05-17 2017-05-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -5.937 0 -100,00
2017-05-17 2017-05-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -3.125 0 -100,00
2017-05-17 2017-05-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -21.041 15.650 -57,35 50,86 -1.070.145 795.959
2017-05-17 2017-05-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 11.979 36.691 48,47 10,81 129.493 396.630
2017-05-17 2017-05-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 5.937 24.712 31,62 10,52 62.457 259.970
2017-05-17 2017-05-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 3.125 18.775 19,97 9,25 28.906 173.669
2016-12-09 2016-12-07 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 20.000 20.000
2016-06-17 2016-06-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 17.500 17.500
2016-06-17 2016-06-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
A - Award 8.750 15.650 126,81
2016-06-08 2016-06-06 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale -600 6.900 -8,00 47,20 -28.319 325.673
2015-06-05 2015-06-03 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 15.000 15.000
2015-06-05 2015-06-03 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
A - Award 7.500 7.500
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)